Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2002

View Archived Issues

New dosage form of Atrix's Leuprogel licensed in by Sanofi-Synthelabo

InKine submits chemistry supplement for new formulation of Visicol for colon cleansing

SpectRx acquires Sterling Medivations

Unexpected gene regulatory effects by probucol and BO-653

Pharmacia granted rights to foam delivery technology for use with Rogaine

Phase IIb clinical trial of NBI-6024 in diabetes set to commence

Pretarget product candidates in phase Ia clinical trials

MAP acquires European rights for Dopascan Injection for Parkinson's disease imaging

Genzyme Genetics acquires diagnostic cancer rights from Genzyme Molecular Oncology

Uridine derivatives with antibiotic properties reported by Aventis

Chugai researchers design vitamin D3 analogues with antipsoriatic activity

Aventis discloses novel vitronectin receptor antagonists

Kyowa Hakko and Lilly report new potent antitumor compounds

Suntory presents new compounds for the treatment of osteoporosis and other bone diseases

Scientists at Sumitomo identify novel PARP inhibitors

Novel betacin antibiotic described by Versicor

SCAP ligands: a promising new class of hypolipidemic drugs

Peptidomimetic exhibits broad antimicrobial and endotoxin-neutralizing activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...